Geron was kneecapped by the FDA hold 4 months ago. The Mayo Clinic had a partial hold also levied on their research. Recently the FDA released the partial hold on the Mayo, and it is assumed GERN will use the same data to sway the FDA into releasing their hold. Also there will be a 1 for 24 share divi for GERN HOLDERS of record of May 28th in a new company Asterias --AST. This will take place before the end of July and should add some notice by the investment community. Mayo Clinic has been VERY bullish on Geron's Imetelstat drug for treating blood cancers and expect to see more data on their trials in the not too distant future. I think the squeezed BBs with bullish indications from both the Stochastics and MACD are indicating a high probability of a short term to intermediate term upwards move.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。